In a murine model of VaD [120,121], low-frequency (inhibitory) rTMS was able to improve cognitive deficit through the up-regulation of the hippocampal brain-derived neurotrophic factor (BDNF) and the expression of the N-methyl-d-aspartate glutamate receptor [122]. The gene discussed is BDNF; the disease is Cognitive impairment.